Mateials and Methods
Methods used for generating CTLs and performing cell-mediated lympholysis (CML) assays in these studies have recently been described (16) . All lymphocytes were Ficoll-Hypaque purified and obtained from healthy nontransfused volunteers . The protocols involved in these suppression studies required CML testing on two target populations that were minimally cross-reactive in the CML assay; however, this, relatively sensitive CML assay detects extensive cross-reactivity between most individuals examined . Therefore, many individuals were screened by prior CML testing to identify five different groups of three donors each . To simplify presentation of data, the responding cell donor in each group is designated A, and the other two B and C. These three individuals were in each case chosen so that CTLs from an AB . culture induced strong specific killing on B targets and low cross-killing on C targets; the CTLs from an AC m culture killed reciprocally .
Results
When fresh lymphocytes from individual A are simultaneously sensitized with mitomycin C-treated cells from B and C (Bm and G,), cytotoxicity is developed against both B and C targets. CML blocking studies have shown that such cultures generate separate populations ofCTLs, one reactive to antigens on B and the other reactive to C (16) . Unlike simultaneous addition of Bm and Cm, the addition of Cm to an ongoing ABm culture that was initiated 2 days earlier induces very little cytotoxicity on C, but allows the development of normal cytotoxicity on B targets. In this case the ongoing AB. culture "pre-empts" the cytotoxic response of the subpopulation of A cells able to recognize C.
An example of CML pre-emption is presented in Table I . In the standard day 6 CML assay, individual A demonstrated great specificity in distinguishing B target cells from C target cells (rows 1 and 2) ; however, even this low level of cross-killing was greater than the "autokilling" (rows 10 and 11) . Rows 3 and 4 represent CTLs obtained from sensitization flasks that contained the same BC.
number ofA, Bm, and C m cells, the only difference being that fresh Cm cells were added on day 2 in row 4, as opposed to on day 0 in row 3. These two populations killed B target cells to the same extent, as did the CTLs sensitized to Bm alone (row 1). Cytotoxicity on C targets by the AB.C. culture (row 3) was similar to that mediated by the AC, culture (row 2) ; both of these were much greater than that mediated by the AB. culture stimulated on day 2 with Cm (ABm-Cm, row 4). The cytotoxicity mediated on C targets by 30 x 104 CTLs from this pre-empted culture (row 4) was 29%, less than that mediated by only 6 x 104 CTLs in rows 2 and 3 . Because peak CML activity is observed 6 days after allogeneic stimulation, it is essential to examine the cytotoxic activity of these cultures on day 8, the expected time of peak response to the stimulating cells added on day 2. Of greatest importance was the cytotoxicity mediated by the "pre-empted" mixture (row 4). Like rows 1 and 3, cytotoxicity on B targets dropped from day 6 to day 8. However, unlike the increased cytotoxicity directed at C targets in rows 6 and 8, the day 8 cytotoxicity on C targets by this pre-empted combination was as low as the cross-killing by ABm on the C targets (row 7) . This indicated that the response of the A lymphocytes to the addition of Cm cells on day 2 was preempted by the ongoing response to B.-stimulating cells. That the Cm cells obtained on day 2 were highly stimulatory was demonstrated by the cytotoxicity on C target cells in rows 6 and 8 ; the percent cytotoxicity was of comparable magnitude to that observed on day 6 using the standard CTLs stimulated on day 0 with Cm cells (rows 2 and 3) . The reciprocal combination and its appropriate controls also demonstrated that the ongoing response to Cm pre-empted the generation of CTLs to B target cells when Bmstimulating cells were added on day 2 (row 5) . This pre-emption is similar to preliminary data obtained in mouse (17) .
In other experiments, pre-emption in man was observed by adding Cm to a 24-h ongoing ABm culture; the pre-emption effect increased slightly from day 1 to 3 (80-96% inhibition of cytotoxic potency). The observation of pre-emption before detectable MLC or CML reactivity and 4-5 days before their peaks would not be expected from a mechanism involving only positive selection for the responding (proliferating) population .
Direct evidence supporting a suppressive mechanism is presented in Table II . Fresh Cmstimulating cells were added to ongoing 2 day ABm or AAm cultures with or without fresh A lymphocytes. The AB. cultures pre-empted the cytotoxic response to fresh Cm alone (row 5 compared to rows 4 and 6). If this preemption were merely selective in nature it would not be expected to influence fresh A lymphocytes from responding to Cm. However, the ongoing ABm culture (row 8), but not the AA,,, culture (row 7), markedly suppressed the expected development of cytotoxicity directed towards C (row 3) when fresh A plus Cm cells were added to them on day 2.
The combinations presented in the last four rows involved the addition of fresh A cells on day 2 and fresh Cm cells on day 3 . Again, the ongoing ABm response initiated on day 0 suppressed the generation of CTLs directed against C. The observed suppressive effect required the responding AB. cells, since the cell-free supernate from a 2 day ABm culture did not suppress (row 12).
In other experiments, cells from a ABm sensitization flask were removed and washed after 2 days of culture and added to fresh A plus Cm cells ; suppression similar to the above was caused by these cells, while the 2 day AB. supernate had no suppressing effect .
To determine where the suppressive mechanism was acting, cells from an ongoing 2-day AB. culture were added to an ongoing 2-day ACm culture. The cytotoxicity observed on day 6 was similar to that from a simultaneously stimulated ABmCm culture, showing no suppressive effect. This suggests that the suppression mechanism demonstrated above involves inhibition of immune recognition or of the early steps in CTL differentiation.
Discussion
These experiments have demonstrated that a cell-dependent suppression of CTL activation is generated in human MLC. Several distinct methods ofgenerating and detecting suppressor activity have recently been described (1) (2) (3) (4) (5) (18) (19) (20) (21) (22) ; aspects of this in vitro suppression in man appear to parallel certain qualities of in vitro induced murine suppression (23) . However, more studies are required to determine the in vivo significance and the specific cellular mechanism of this suppression. Many complex models could be constructed to account for the phenomena, yet this seems unwarranted until more insight is provided . At present, two conclusions can be derived from these studies. Firstly, cell-mediated suppression of immune responses can be generated and studied in vitro using human lymphocytes responding to allogeneic cells. Secondly, the specificity of secondary responses to alloantigens after sensitization in MLC represents, at least in part, a "pre-emption" of third-party responsiveness by this suppression mechanism .
